Key Highlights

  • WiMi Hologram Cloud (NASDAQ:WIMI) was quoted at USD 0.5899, up 13.01%, after a Nasdaq notice dated October 30, 2026 with a compliance deadline of April 28, 2027.
  • SunCar Technology Group (NASDAQ:SDA) was quoted at USD 0.23, up 11.65%, and needs a gain of about 335% to reach USD 1.00, simple arithmetic on the premarket quote.
  • Virtuix Holdings (NASDAQ:VTIX) was quoted at USD 0.60, up 9.89%, with Going Concern language in its filing. Ocugen (NASDAQ:OCGN) was quoted at USD 0.96, up 9.78%, after its third quarter update.
  • Arcadia Biosciences (NASDAQ:RKDA) was quoted at USD 0.1711, up 8.15%, with a filing that raises substantial doubt about its ability to continue as a going concern.

WiMi Hologram Cloud (NASDAQ:WIMI)

WiMi Hologram Cloud (NASDAQ:WIMI), whose Class B ordinary shares trade on the Nasdaq Global Market, disclosed in a Form 6-K dated November 2, 2026 that it received a deficiency letter on October 30, 2026. Listing Rule 5450(a)(1) requires a USD 1.00 minimum bid, and the closing bid stayed below it for 30 consecutive Business days from September 18, 2026 to October 29, 2026. The letter has no immediate effect on trading. In premarket trading on November 5, 2026, per the premarket quote, the shares were at USD 0.5899, up 13.01% from a prior close of roughly USD 0.52, simple arithmetic. The company has 180 calendar days, to April 28, 2027, and needs a closing bid of at least USD 1.00 for 10 consecutive business days. It said it will evaluate options, including seeking Shareholder approval for a reverse split. A reverse split consolidates shares, so 10 into 1 lifts the quote tenfold but leaves Market Value unchanged at that moment. Published coverage of 2025 Net Income of RMB 347 million is a single headline and not confirmed. Quoted moves in sub-dollar shares can reverse.

SunCar Technology Group (NASDAQ:SDA)

The stock sits roughly 77% below the line that matters for its listing. At USD 0.23 in premarket trading on November 5, 2026, up 11.65% per the premarket quote, SunCar Technology Group (NASDAQ:SDA) needs a rise of about 335% to reach USD 1.00, simple arithmetic. Nasdaq flagged the shortfall on July 27, 2026, and the company disclosed it in a Form 6-K exhibit on July 30, 2026. The compliance clock ends January 25, 2027. Beyond the bid rule, a closing bid of USD 0.10 or less for 10 consecutive trading days would trigger a staff delisting determination, which the company could appeal to a hearing panel. The company describes itself as an AI-powered business-to-business auto insurance and services provider in China, founded in 2007. Full-year 2025 results were published on April 28, 2026, though the figures were not reviewed. As a foreign issuer it reports on Form 6-K, so watch for a shareholder meeting notice proposing a share consolidation. Nano-cap quotes can reverse.

Virtuix Holdings (NASDAQ:VTIX)

The cash runway is the story. Virtuix Holdings (NASDAQ:VTIX) was quoted at USD 0.60 in premarket trading on November 5, 2026, up 9.89%, per the premarket quote. At June 30, 2026 it held USD 7,443,869 of cash, down from USD 9,471,288 at March 31, 2026, and operating cash use of USD 3,294,829 in the quarter implies about 2.3 quarters of cover, simple arithmetic. The filing states that losses and limited Working Capital raise substantial doubt about continuing as a going concern within one year. Against that, the maker of the Omni One motion platform reported new orders up 72% year on year, a gross Margin of 30% against 17%, and a planned Marine Corps pilot delivery to Quantico, Virginia, in the fourth quarter of calendar 2026. Revenue fell 26% to USD 767,300. With 29,971,349 Class A and 4,000,000 Class B shares at August 18, 2026, the quote implies a value near USD 20 million. New financing would likely dilute holders, and the quote can reverse.

Ocugen (NASDAQ:OCGN)

The gene therapy developer is the only name in this group quoted close to the line. It was at USD 0.96 in premarket trading on November 5, 2026, up 9.78% per the premarket quote, after a third quarter business update and quarterly report, with the filing date inferred as November 4, 2026. Cash, restricted cash and short-term investments were USD 84.6 million at September 30, 2026, up from USD 18.9 million at December 31, 2025. The net loss narrowed to USD 3.6 million from USD 20.1 million, helped by a USD 16.6 million non-cash derivative gain, so simple arithmetic puts the underlying loss near USD 20.2 million. Topline data for OCU400 in retinitis pigmentosa are expected in the first quarter of 2027, with a Biologics license application in the second quarter of 2027. The quarterly filing states substantial doubt about continuing as a going concern and gives no funding runway. With 339.3 million shares outstanding, the quote implies a value near USD 326 million, simple arithmetic. Dilution and trial outcomes are the risks.

Arcadia Biosciences (NASDAQ:RKDA)

The smallest quote in the group comes with the least reassurance. Arcadia Biosciences (NASDAQ:RKDA) was quoted at USD 0.1711 in premarket trading on November 5, 2026, up 8.15%, per the premarket quote. Its latest report, the 10-Q for the quarter ended June 30, 2026, showed revenue of USD 1.44 million, a net loss of USD 6.27 million and cash of USD 4.18 million. The filing says cash will not cover at least the next 12 months and raises substantial doubt about continuing as a going concern, naming financings or asset sales as options. The Roosevelt Resources combination was terminated on December 26, 2025, and the company resumed evaluating strategic alternatives. About 2.7 million shares of Above Food Ingredients, now quoted over the counter, are carried at zero. Published market data, approximate and from one page, put the market value of listed securities near USD 381.1 thousand against a USD 5.00 million Nasdaq floor. A small number of trades can move this price and spreads can be wide.

Where Things Stand

The five share one trait, a quote below USD 1.00, and the balance of evidence is that the risk lies in listing rules, cash and dilution rather than in the size of the premarket gains. WiMi Hologram Cloud (NASDAQ:WIMI) faces a dated Nasdaq cure period. SunCar Technology Group (NASDAQ:SDA) faces one too. Virtuix Holdings (NASDAQ:VTIX) carries going concern language. Arcadia Biosciences (NASDAQ:RKDA) does as well. Ocugen (NASDAQ:OCGN) has a stronger cash position and a defined 2027 data timeline, though its improved loss leaned on a non-cash gain. Every figure here is a premarket quote on November 5, 2026, and sub-dollar quotes can reverse by the open.